EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study-Reference-Cited by-同舟云学术

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study

Published:2022-06 Issue:6 Volume:23 Page:758-767
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zauderer Marjorie G,Szlosarek Peter W,Le Moulec Sylvestre,Popat Sanjay,Taylor Paul,Planchard David,Scherpereel Arnaud,Koczywas Marianna,Forster Martin,Cameron Robert B,Peikert Tobias,Argon Evren Kocabaş,Michaud Neil R,Szanto Attila,Yang Jay,Chen Yingxue,Kansra Vikram,Agarwal Shefali,Fennell Dean A

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

2. Integrative molecular characterization of malignant pleural mesothelioma;Hmeljak;Cancer Discov,2018

3. Loss of BAP1 function leads to EZH2-dependent transformation;LaFave;Nat Med,2015

4. PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation;Almeida;Science,2017

5. hnRNPK recruits PCGF3/5-PRC1 to the Xist RNA B-repeat to establish Polycomb-mediated chromosomal silencing;Pintacuda;Mol Cell,2017

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing precision: A review of targeted approaches in pleural mesothelioma;Critical Reviews in Oncology/Hematology;2024-11

2. Malignant Pleural Mesothelioma: Socioeconomic and Clinical Aspects;Current Cancer Therapy Reviews;2024-07-23

3. Advances in biology, diagnosis and treatment of DLBCL;Annals of Hematology;2024-07-17

4. Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry;Biomedical Chromatography;2024-05-23

5. Targeted Therapy in Mesotheliomas: Uphill All the Way;Cancers;2024-05-22